C
HICAGO – The faltering economy and burgeoning federal budget
deficit may be wreaking havoc on hospital planning and purchasing with a
growing number of organizations circling the wagons until the dust clears.
What that means, according to recent studies by the American Hospital
Association, is that more than half of hospitals either are postponing or
rethinking hospital improvement projects and acquiring "critical" equipment.
The ripple effect can only lead to higher prices for products as demand and
investment slides.
At the 2008 Radiological Society of North America (RSNA) conference and
exhibition in early December, Healthcare Purchasing News Senior
Editor Rick Dana Barlow sat down with Antoinette Gawin, chief marketing
officer, GE Healthcare Financial Services in the company’s massive exhibit
space in the South Hall of Chicago’s McCormick Place to gauge her
impressions and glean her insights as to what the future may hold for
hospital finances, particularly as it relates to supply chain activities.
Gawin has spent more than two decades at GE in a variety of high-level
executive management roles for several divisions, before helping to shape
the company into a "customer-focused organic growth engine" from an
"engineering-led organization."
In her current role, Gawin oversees growth strategies, including new
market identification and penetration, portfolio management and functional
marketing support. Prior to this role, Gawin spent five years at GE
Healthcare leading strategic marketing and established its customer advocacy
function.
HPN: Now that we’re officially in a recession that federal officials have
acknowledged began in 2007, what does this mean for hospitals and other
healthcare facilities?
 |
|
Antoinette Gawin |
GAWIN: Near-term, I believe the biggest impact will be decreased
volume as people defer discretionary procedures, or hold off a bit longer on
required surgeries that require significant out-of-pocket expenses or time
off from work. From a macro perspective, as unemployment rises, I would
anticipate an increase in bad debt as folks lose insurance coverage.
How is the slumping economy, pogo-sticking stock market (such as the Dow
Jones Industrial Average) and indecision about federal bailouts of various
industries affecting capital dollars for healthcare facilities?
We’ve already seen an impact in the market as public insurers have
reneged on their commitments. This previously enabled the daily cash flow at
many large healthcare systems. GE is one of the few private entities that
has the capability to step in, but given the daily fluctuations in policy
that impact immediate cost of capital, waiting for the market to settle may
be the most prudent course of action.
Some observers say that capital dollars either won’t be available for
healthcare facilities or they’ll be available at higher rates or even tied
to performance measures, including quality and safety initiatives (as in
medical error reduction). Thoughts?
I anticipate that capital will be deployed cautiously, with an emphasis
on sound operations and underlying volume fundamentals. As an example, are
you in a strong competitive position locally? This could mitigate volume
loss in a downturn.
In terms of qualifying for capital, you may see more covenants that
encourage operational improvements, protections against variable rate
volatility and increased collateral requirements. I haven’t seen anything as
specific as medical error reductions, but I do know that the various reform
proposals being debated in congress do include differing reimbursement
schemes to encourage adoption of patient safety measures.
With the Deficit Reduction Act and the economy disrupting the healthcare
industry’s finances, operations and overall mindset, how do you see it
affecting technology adoption and implementation on the provider side, as
well as technology development and pricing on the supplier side?
Historically, providers delay technology purchases in an election year.
As healthcare grows as a component of our federal deficit, this increases
the pressure to take cost out of the system. Given the size of our federal
deficit, and more importantly, the enormous concern of fiscal solvency at
the state level, funding for providers will be scrutinized even more.
The [American Hospital Association] recently reported that 45 percent of
hospitals are delaying technology and clinical investment. Fifty percent of
hospitals indicated they are cutting administrative and personnel costs, and
27 percent are decreasing their services. This has an obvious ripple effect
through the supply chain.
The incoming Obama administration promised healthcare reform plans as
early as late 2009. What might those plans involve and how will capital
availability, reimbursement dollars and technology development and
acquisition be affected?
Various groups – Bacchus, Kennedy, Gingrich, etc., have developed white
papers or road maps outlining approaches to reform. A few common elements
that appear to have bi-partisan support include: 1. Expanding coverage for
children. SCHIP was vetoed by [President] Bush based on immigration
concerns, but had majority in both houses; 2. Providing funding incentives
to adopt EMR/EHR and IT infrastructure; 3. Harmonizing the payment system
between [Medicare Advantage], [Veterans Administration],
inpatient/outpatient, etc. As an illustration, Kaiser Foundation reports
that a procedure performed on a patient enrolled in Medicare Advantage costs
12 percent to 17 percent more than the national average.
Will President Obama and Secretary of Health and Human Services Tom
Daschle be good for healthcare’s business climate? Or at least better than
their predecessors?
Obama and Daschle are both pragmatic leaders, who have clearly indicated
that healthcare is on their agenda. It has not been high priority on the
agenda of recent administrations. Obama’s role on the Senate HELP committee,
which appropriates significant dollars for healthcare, has given him more
detailed perspective on the issues. Compared to the efforts under the
Clinton administration, not only have there have been broader bipartisan
efforts and industry engagement, the sheer size and growth rate of our
healthcare spending, and underlying demographic demands make it a key issue
to restoring fiscal stability. 
